A Boston federal judge has imposed a $321.6 million criminal fine against Merck & Co. Inc. for its Vioxx promotion and marketing activities, bringing the company’s payout in recent months to nearly $1 billion for illegal marketing.
On April 19, U.S. District Judge Patti Saris of the District of Massachusetts imposed the fine against Merck’s U.S. unit following its December 2011 guilty plea. Merck violated the Food, Drug and Cosmetic Act by introducing a misbranded drug into interstate commerce.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
